Articles

Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial

Nissen SE, Linnebjerg H, Shen X, et al.

First published: November 12, 2023  DOI: 10.1001/jama.2023.21835